# FDA Inspection 1201266 - Synapse Labs Pvt. Ltd. - March 09, 2023

Source: https://www.keypedia.com/records/fda_inspections/synapse-labs-pvt-ltd/7e351254-5993-4648-86cb-b43db77b6169
Source feed: FDA_Inspections

> FDA Inspection 1201266 for Synapse Labs Pvt. Ltd. on March 09, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201266
- Company Name: Synapse Labs Pvt. Ltd.
- Inspection Date: 2023-03-09
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1123667 - 2020-02-21](https://www.keypedia.com/records/fda_inspections/synapse-labs-pvt-ltd/e9f74844-00d9-4408-a2fa-9ae8849f2cbd)

Company: https://www.keypedia.com/companies/synapse-labs-pvt-ltd/8c479822-ed2a-4553-b285-e522198df344

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c